All updates
All updates
today 37文献与产业新闻评分1414 文献与产业新闻评分1414 Novo struggles to appease restive investors with consumer plans, blockbuster ambitions
文献与产业新闻评分3434 Bayer offloads cancer drug Stivarga to Grünenthal for up to $431M as new competition looms
文献与产业新闻评分2020 STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer work
文献与产业新闻精选评分6161 Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition
文献与产业新闻评分2828 Retension and Lilly-backed TRex Bio both set out plans to join biotech IPO stampede
中文产业新闻精选Chinese source评分6262 Telix 以约16.5亿美元收购ITM Isotope Technologies Munich
文献与产业新闻精选评分6565 STAT+: Radiopharma companies merge after one receives surprise FDA rejection
文献与产业新闻评分1111 Sanofi vet Tarja Stenvall to lead Bavarian Nordic
文献与产业新闻评分1414 STAT+: In a fight over denied claims, HCA sues out-of-state Blue Cross Blue Shield plan
文献与产业新闻评分2121 Electra dips after pricing upsized IPO, bucking trend: Public Equity Report
文献与产业新闻评分1313 STAT+: Roche expands its Boston footprint with new research center
文献与产业新闻评分1111 STAT+: Up and down the ladder: The latest comings and goings
文献与产业新闻评分3333 Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope
文献与产业新闻评分1515 Fierce Pharma Asia—China deals safe from COINS?; Key WCLC data; Legend’s new CEO
文献与产业新闻精选评分3737 Inflammation biotech Electra charges up with $350M from upsized IPO
文献与产业新闻评分2828 With Tepezza challenge in late-stage study, Sling draws $123M series C: Venture Report
文献与产业新闻评分1515 Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential
文献与产业新闻评分1616 STAT+: Zocdoc for chatbots and what’s new with Medicare’s ACCESS
文献与产业新闻评分1212 Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol
文献与产业新闻评分1414 Bavarian Nordic secures Sanofi, AZ vet to fill shoes of longtime CEO Paul Chaplin
文献与产业新闻评分1313 STAT+: A biotech hedge fund births a new immunology company
文献与产业新闻评分77 Eli Lilly dishes out fresh produce to cultivate Alzheimer’s awareness
文献与产业新闻评分2020 After one failed acquisition attempt, Lisata finds lifeline in Marea merger
文献与产业新闻评分44 Sun Pharma shines a light on alopecia areata in ‘Regrowth Restyled’ campaign
文献与产业新闻评分88 ‘People like the sincerity of it’: comedian Damon Wayans on humor, relatability and DME awareness in Genentech campaign
文献与产业新闻精选评分4242 Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive
文献与产业新闻评分1818 North Immunology goes public via reverse merger as eczema drug heads toward clinic
文献与产业新闻评分1010 Ex-PHM CEO Andrea Palmer takes top job at Assembled Intelligence
文献与产业新闻评分3030 SK pens $315M pact with fellow South Korean company for Parkinson’s prospect
文献与产业新闻评分2222 Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts
文献与产业新闻评分77 Trialynx Wins DPHARM Idol Disrupt 2026
文献与产业新闻评分2020 BMS, Ono take Amgen to task as FDA's Opdivo biosimilar decision looms
文献与产业新闻评分2727 Legend Biotech names Novartis veteran Ingrid Zhang as new CEO
文献与产业新闻评分3333 Ori locks down $120M pact to deploy automated production platform for unnamed commercial cell therapy
文献与产业新闻评分3232 Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotech
文献与产业新闻精选评分4949 Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier
文献与产业新闻评分1717 Novartis commercial leader Ingrid Zhang named Legend CEO
文献与产业新闻评分4343 Sling reels in $123M series C to fund oral Tepezza rival through phase 3 trial
文献与产业新闻评分1717 STAT+: Obesity drugmakers are testing in kids as young as 6